- Calendar of Events
- Caring for Our Community 2013
- Community Service Plan
- Contact Us
- James House Mansion
- Mission & Vision
- NYMC Phelps Family Medicine Residency Program
- Phelps Hospital Affiliations
- Phelps Hospital Annual Reports
- Phelps Hospital News
- Phelps Hospital Phone Directory
- Phelps Today Magazine
- Senior Management Staff
- Vital Signs Videos
Phelps Is First Hospital in U.S. to Install Ivenia Automated Breast Ultrasound System for Screening of Dense Breasts
(June 3, 2014) GE Healthcare today announced FDA approval and the U.S. launch of their new breast imaging technology, the Invenia ABUS, proven to help clinicians find 35.7% more cancers in women with dense breasts than mammograms alone. *
In keeping with a strong commitment to furthering the fight against breast cancer, GE Healthcare today unveiled the first Invenia ABUS installations at Phelps Memorial Hospital Center in Sleepy Hollow, NY, and Fairfax Radiological Consultants outside of Washington, D.C. The new technology enables healthcare providers to offer women with dense breast tissue an efficient, comfortable and non-ionizing screening solution.
“Phelps Memorial Hospital Center prides itself on keeping up with cutting-edge technologies, and we are very excited to integrate ABUS into our mammography program,” noted Michael Glennon, Senior Administrative Director of Ancillary Services at Phelps. “This highly sophisticated system is more efficient than the traditional ultrasound exam and will significantly enhance our diagnostic capabilities and potentially improve outcomes for our patients.”
The Invenia ABUS enhances the patient experience by using 3D ultrasound technology to comfortably and quickly image women with dense breast tissue in approximately 15 minutes with new features that conform to a woman’s body and provide more enhanced images. This launch comes at a critical time when there is growing awareness of the increased risk of cancer for women with high breast density. The more dense breast tissue a woman has, the higher her risk of developing breast cancer** – often up to 4-6 times greater risk than women who do not have dense breast tissue. ***
“A growing body of research suggests the importance of screening ultrasound for women with dense breast tissue–that’s about 40% of women,” said breast imaging specialist Elise L. Berman, M.D., of Fairfax Radiological Consultants. “Mammography is still considered the gold standard for breast cancer screening but is less sensitive in women who have dense breast tissue. Supplementing the mammogram with automated breast ultrasound screenings should help us find tumors that cannot be seen on the mammogram and at an earlier stage than would have otherwise been found. We are optimistic that this more personalized screening approach can help us save more women’s lives.”
Recognizing that breast cancer screenings can be an emotionally stressful experience for the patient, GE Healthcare has designed the Invenia ABUS with the patented Reverse Curve transducer to conform to a woman’s anatomy, for better comfort and image performance. Further, the system uses Compression Assist, a feature which applies light levels of compression automatically to the breast for increased ease and image reproducibility. Following on the initial Sleepy Hollow and Fairfax launches, GE plans to roll out the Invenia ABUS nationwide this year, with health providers across the country.
“We are excited about launching our most innovative and intuitive ABUS system yet, the Invenia ABUS, and are proud to make our first installs at the renowned facilities at Phelps Memorial and Fairfax Radiological Consultants,” said Anders Wold, president and CEO of GE’s ultrasound business. “As part of our ongoing commitment to improving women’s health, GE Healthcare is focused on providing timely and meaningful technological innovations spanning the care continuum, including those for the screening of patients with dense breasts.”
About GE Healthcare
GE Healthcare provides transformational medical technologies and services to meet the demand for increased access, enhanced quality and more affordable healthcare around the world. GE (NYSE: GE) works on things that matter – great people and technologies taking on tough challenges. From medical imaging, software & IT, patient monitoring and diagnostics to drug discovery, biopharmaceutical manufacturing technologies and performance improvement solutions, GE Healthcare helps medical professionals deliver great healthcare to their patients.
About Phelps Memorial Hospital Center
Phelps Mem orial Hospital Center is a 238-bed acute care community hospital in Sleepy Hollow with more than 1,600 employees and 475 medical staff members representing 50 medical specialties. Phelps offers one of the broadest ranges of community hospital services in Westchester. Patients benefit from distinguished physicians, many of whom are pioneers in their field, offering the most advanced procedures using the latest technology. www.phelpshospital.org
* FDA PMA P110006 summary of safety and effectiveness.
**Boyd NF et al. Mammographic Density and the Risk and Detection of Breast Cancer. NEJM 2007; 356: 227-36. Boyd, et al, NEJM Jan 2007.
*** Tabar L, et al. Swedish two county trial: impact of mammographic. 2011;260:658 63.
SOURCE GE Healthcare